Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 268 participants.
Also called NCT05655468
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 268 participants
- Sponsor
- Registry
-
NCT05655468
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05655468. Randomized; quadruple masking; primary purpose treatment. Start 2023-03-29 (actual); primary completion 2025-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation
- Acronym
- DORIS
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Dronedarone
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shanghai East Hospital
Record details
- Record id
cardio:ct-nct05655468- Content hash
6aa2d9eb43b80888fcd7cb56a80da49324e5245c2d0e4be0670ff27c9c979ac5